Abstract
Chinese medicine (CM) decoction placebo is one of the key factors restricting the placebo-controlled clinical trial of CM. In this article, based on the analysis of the diffificulties in preparing CM placebo, the production requirements for placebo were put forward. Moreover, in accordance with clinical practices, a production method and evaluation process of CM decoction placebo was proposed, to provide a reference for clinical research.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Wu SP, Xu LP, Guo Y, Cui YS, Zhao XY, Li Y, et al. Current application of placebo in Chinese clinical studies in past 30 years. China J Chin Mater Med (Chin) 2015;40:1410–1414.
Bi JF, Duan JG, Liu ZM. Discussion on the effect of placebo control in randomized controlled trials (RCTs). Pharmacol Clin Chin Mater Med (Chin)2007;23:59–61.
Wang YF, Ruan XM, Wu HL, Ou AH,Cao BJ, Mu QY, et al. Preparation of Chinese herbal medicine placebos and efficacy evaluation in large-scale double-blind clinical trails. Tradit Chin Drug Res Clin Pharmacol (Chin) 2011;22:255–258.
Wu J. Placebo control and clinical trial of Chinese medicine. J Chin Integr Med (Chin) 2010;8:906–910.
Liu JJ, Guo YM. Problems of TCM clinical trials. Progr in Jap Med (Chin) 2003;24:91–93.
Wang XF, Dong D, Liu F, Li Jie, Lu Ying. Exploration of placebo preparing in TCM clinical researches. Liaoning J Tradit Chin Med (Chin) 2003;30:966–967.
Tang XD, Bian LQ, Gao R, Guan SJ. Exploration into the preparation of placebos used in Chinese medicinal clinical trial. Chin J Integr Tradit West Med (Chin) 2009;29:656–658.
Lin M, Tang XD, Wang FY, Bian ZX, Yang JQ. Effects of low-concentration ’Chang An ?’ placebo on visceral hypersensitivity in diarrhea-predominant IBS rats. Shanghai J Tradit Chin Med (Chin) 2010;44:88–90.
Lin M, Tang XD, Wang FY. Pharmacodynamics study on Chang’an ? and control placebo containing low concentration original drug. Shenzhen J Integr Tradit Chin West Med (Chin) 2009;19:273–278.
Dai XB, Sun XM, Jiang PJ, Ni HW, Chen JY, Zhang WX. Modified Shengma Biejia decoction combined with CAG program for elderly acute myeloid leukemia patients with yin deficiency toxin stasis syndrome. Chin J Integr Tradit West Med (Chin) 2016;36:149–154.
Chen R, Zhou YF, Zhang ZY, Geng L, Lin SQ. Treatment for premenstrual syndrome with Vitex agnus castus: a prospective, randomised, plaeebo controlled, multicenter study in Chinese women. J Reprod Med (Chin) 2011;20:452–457.
Caroli A, Perico N, Perna A, Antiga L, Brambilla P, Pisani A, et al. Effect of longacting somatostatin analogue on kidney and cyst growth in autosomal dominant polycystic kidney disease (ALADIN): a randomised, placebo-controlled, multicentre trial. Lancet 2013;382:1485–1495.
Lin XJ, Li R. Reflections into the latent contradictions between the "placebo" concept and traditional Chinese medicine. Chin Acupunct Moxibust (Chin) 2013;33:269–272.
Author information
Authors and Affiliations
Corresponding author
Additional information
Support by National Key Technology R&D Program during the "Twelfth Five-year" Plan Period (No. 2013BAI02B05), Miaopu Program of Xiyuan Hospital of China Academy of Chinese Medical Sciences [No. XYKY-MP(2013)-7]
Rights and permissions
About this article
Cite this article
Bian, Lq., Li, Bs., Li, Zh. et al. A preparation model of Chinese medicine decoction placebo. Chin. J. Integr. Med. 23, 631–634 (2017). https://doi.org/10.1007/s11655-016-2538-6
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11655-016-2538-6